CLPBF (Coloplast AS) Interest Expense: $-161 Mil (TTM As of Mar. 2026)

What is Coloplast AS Interest Expense?

Coloplast AS CLPBF -0.88% 72 Interest Expense is $-161 Mil as of Mar. 2026. GuruFocus rates CLPBF with a GF Score™ of 72/100 and a GF Value™ of $125.62 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Coloplast AS's interest expense for the three months ended in Mar. 2026 was $ -29 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-161 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Coloplast AS's Operating Income for the three months ended in Mar. 2026 was $ 282 Mil. Coloplast AS's Interest Expense for the three months ended in Mar. 2026 was $ -29 Mil. Coloplast AS's Interest Coverage for the quarter that ended in Mar. 2026 was 9.68. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Coloplast AS (OTCPK:CLPBF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Coloplast AS's Interest Expense for the three months ended in Mar. 2026 was $-29 Mil. Its Operating Income for the three months ended in Mar. 2026 was $282 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $3,402 Mil.

Coloplast AS's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	281.503	/	-29.078
	=	9.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Coloplast AS Interest Expense Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Interest Expense can be seen below:

Coloplast AS Interest Expense Chart

Coloplast AS Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

Interest Expense

Get a 7-Day Free Trial

-3.96

-22.88

-91.30

-118.34

-118.42

Coloplast AS Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-45.80	-75.76	-30.19	-25.71	-29.08

72GF Score

Coloplast AS CLPBF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Coloplast AS Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-161 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-161 Mil mean?

Coloplast AS (CLPBF) has a Interest Expense of $-161 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Coloplast AS and its competitors.

Is Coloplast AS's Interest Expense too high?

Coloplast AS's current Interest Expense is $-161 Mil. Overall, Coloplast AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Coloplast AS's Interest Expense compare to ISRG and BDX?

Coloplast AS's Interest Expense of $-161 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Coloplast AS and its competitors. Coloplast AS's current Interest Expense is $-161 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Coloplast AS stock overvalued right now?

Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $125.62, compared to a current price of $56.90 — trading 54.7% below its estimated fair value. The current Interest Expense is $-161 Mil. Coloplast AS's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Interest Expense is $-161 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (CLPBF) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of $56.90 is trading 54.7% below its estimated GF Value™ of $125.62. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for CLPBF:

Interest Expense: $-161 Mil
GF Value™: $125.62 vs. price of $56.90 (54.7% below fair value)
GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coloplast AS Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OCSE:DEMANT OCSE:AMBU B OCSE:GN OCSE:EMBLA OCSE:CHEMM OCSE:VIRO OCSE:SMSMED ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543 XPAR:DIM COO SOLV

Other Exchanges CLPBY:USA COLOBc:UK 0QBO:UK COLO B:Denmark CBHD:Germany COLO:Austria

Address Holtedam 1-3, Humlebaek, DNK, DK-3050

Website https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

72GF Score

Get the complete analysis for CLPBF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$56.90

Price

$125.62

GF Value

View CLPBF Analysis

See Interest Expense data for all stocks →